Probiotics China News Bites – April 2022

  • Probiotics China team interviewed Sacco CSL with its CEO for Asia-Pacific, Mr. John Goebel. Link to interview is HERE. (Interview is in Chinese)
  • Two Probiotics related products from AB-Biotics, the Lipigo and AB-21 won the 2022 Nutraingredients Awards.
  • AB-Biotics presented its starter product Yogumel for making yogurt or kefir at the Alimentaria food show in Barcelona.
  • Novozymes released the results of the clinical study conducted at the Avicenna Hospital in France : Effect of Bifidobacteri-umlongum 35624 on disease severity and quality of life in patients with irritable bowel syndrome.
  • ADM and Weifang Weizhilan Biotechnology Co., Ltd., a wholly-owned subsidiary of QingDao Vland Biotech, completed the business registration change procedures for capital increase, and changed its name to ADM-Vland Biotechnology (Shandong) Co., Ltd. This company will serve as a business platform for Vland’s human-use probiotics.
  • Bifidobacterium infantis M-63 of Morinaga obtained GRAS from FDA.
  • IFF has completed the acquisition of Health Wright Products, a US dietary supplement capsule manufacturer, to support the probiotics business.
  • The strain L.Casei 21 independently developed by Zhongke JiaYi, has obtained the patent authorization from the South African Patent and Trademark Office.
  • YiLi launched a 100% sugar free probiotics beverage with its self-owned strain, the Lactobacillus paracasei K56.
  • ProBiora Health is promoting a probiotic lozenge designed to support children’s oral health and overall health.
  • By-health stated that it will focus on promoting immunity-enhancing products such as Life Space probiotics
  • Scitop Bio released the 2021 annual report and the 2022 first quarter report which show that the company achieved an operating income of 365 million yuan in 2021, increased by 7.51%. The recent 5 years compound growth rate of edible probiotics business reached 122%.
  • FrieslandCampina has reached a cooperation with the “Probiotic Science and Technology” team of Jiangnan University. This joint project is designed to study the functional effects of GOS and HMO as single and combined raw materials on microbial strains, respectively. This study will further confirm the health effects of GOS and HMO in supporting gut health.
  • Qiansheng Biotech’s new plant with an annual output of 10 thousand tons of Probiotics was successfully constructed and it is expected to be fully completed by the end of August.
  • “WonderLab” launched new products: children’s probiotics, probiotic tablet candies
  • Shaklee launched a new product “Xianqi Probiotic Solid Drink” online in a live-streaming event.
  • The director of the Department of International Trade Promotion of the Ministry of Commerce of Thailand revealed that Chinese consumers have increasing demand for food, beverages and consumer goods containing probiotics, so such products from Thailand are expected to enter the Chinese market.
  • Probi’s first batch of dairy-free immunization strain BLIS K12 went into market.
  • Kerry’s new liquid Bacillus coagulans BC30 will expand into new areas such as plant milk.
  • Seed Health launched pediatric synbiotic product with randomized, double-blind clinical validation.

Visit HPA-China’s Information Hub, CLICK HERE